SYRE
Spyre Therapeutics Inc.
$51.77
$0.00(0.00%)
57
Overall
60
Value
91
Tech
21
Quality
Market Cap
$1.65B
Volume
585.55K
52W Range
$10.91 - $51.06
Target Price
$60.79
Latest News for SYRE
Analysts Conflicted on These Healthcare Names: Amgen (AMGN), ProQR (PRQR) and Spyre Therapeutics (SYRE)
Brian Anderson•a day ago•Apr 09, 2026
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), ProQR (PRQR) and Spyre Therapeutics ......
Stifel Nicolaus Remains a Buy on Spyre Therapeutics (SYRE)
TipRanks Auto-Generated Intelligence Newsdesk•19 days ago•Mar 22, 2026
Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Spyre Therapeutics today and set a price target of $92.00. Thompson CFA covers......
Spyre Therapeutics (SYRE) Receives a Rating Update from a Top Analyst
TipRanks Auto-Generated Intelligence Newsdesk•20 days ago•Mar 21, 2026
In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics, with a price target of $64.00. Slutsky ......
Analysts’ Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), Spyre Therapeutics (SYRE)
Howard Kim•25 days ago•Mar 17, 2026
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oneview Healthcare Chess Depository Interests repr 1......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $51.77 | 0% | 585.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |